VTE Flashcards
NOACs/DOACs
-direct thrombin inhibitor (dabigatran)
-factor Xa inhibitors (rivaroxaban, apixaban, edoxaban)
Dabigatran VTE indications
-postop prophylaxis (hip)
-Afib
-DVT/PE tx
NOAC indications
-all Afib and DVT/PE tx
Rivaroxaban indications for VTE
-post-op prophylaxis
-prevention of recurrent DVT/PE
-VTE prophylaxis
-Afib and DVT/PE tx
Apixaban indications
-pot-op
-precention of DVT/PE
-afib and DVT/PE tx
Edoxaban VTE indication
-only afib and DVT/PE tx
Dabigatran dosing for post-op prophylaxis
-110mg qd (1-4 after and hemostasis)
-not on 220mg qd 28-35 days
-hip replacement only
Afib dosing
-20mg Rivaroxaban qd
-60mg Edoxaban qd
-Apixaban*
Apixiban for afib dosing
-renal adjustment if SCr < 1.5mg/dl, over age 80 under 60kg = 2.5mg BID (needs only 2 factors)
-ESRD on dialysis: 5mg BID reduce to 2.5mg if over 80 and under 60kg
Edoxaban for afib
-60mg qd
-do not use if CrCl >95ml/min
DVT/PE tx dosing
-Dabigatran requires 5-10days parenteral anticoagulation
-Rivaroxaban 15mg BID x 3 weeks then 20 mg qd
-Apixaban 10mg BID x 7 dyas then 5mg BID
-Edoxaban 60mg (30mg if under 60kg) and requires 5-10 day parenteral anticoagulation
Prevention of recurrent DVT/PE dosing
-Rivaroxaban 20 mg
-Apixaban 2.5mg BID
-after initial 6 months of treatment
VTE prophylaxis dosing
-Rivaroxaban 10mg qd 31-39 days
Warfarin dosing
-5mg qd initial
-10mg qd x 2 days if healthy outpatient
-overlap w UFH/LMWH/Xa for at least 5 days and until INR is therapeutic
-adj weekly dose to acheive therapeutic INR
Recommended INR goal of 2-3
-prophylaxis of VTE
-tx of VTE or PE
-prevention
-antiphoshpholipid antibody system
-MECHANICAL VALVE AORTIC